The link between protein aggregation and neurodegenerative disease is well established. However, given the heterogeneity of species formed during the aggregation process, it is difficult to delineate details of the molecular events involved in generating pathological aggregates from those producing soluble monomers. As aberrant aggregates are possible pharmacological targets for the treatment of neurodegenerative diseases, the need to observe and characterise soluble oligomers has pushed traditional biophysical techniques to their limits, leading to the development of a plethora of new tools capable of detecting soluble oligomers with high precision and specificity. In this review, we discuss a range of modern biophysical techniques that have been developed to study protein aggregation, and give an overview of how they have been used to understand, in detail, the aberrant aggregation of amyloidogenic proteins associated with the two most common neurodegenerative disorders, Alzheimer's disease and Parkinson's disease.
Introduction
Finding an effective therapy for neurodegenerative diseases is one of the most pressing issues in society. The difficulty of this task is partially due to the lack of a precise understanding of the mechanisms underpinning the diseases. Common neurodegenerative disorders are characterised by progressive neuronal cell loss and the presence of protein aggregates in the affected and surrounding areas of the brain [1] [2] [3] [4] . In the context of research into neurodegenerative diseases, the association of these disorders with the aggregation of a specific protein is a relatively recent advance. Whilst the two most common dementias, Alzheimer's disease (AD) and Parkinson's disease (PD), were first described more than a century ago [5, 6] , it took more than 75 years to identify the main components of the deposits found in these diseases: in 1985, the peptide amyloid-b (Ab) was identified as a main component of the extracellular plaques found in AD [7] and shortly thereafter neurofibrillary tangles (NFTs) were shown to primarily consist of the microtubule-associated protein tau [8] [9] [10] [11] . Subsequently, a-synuclein (aS) was identified as main component of Lewy bodies typically present in PD brains [12] . These pivotal discoveries have sparked a vast amount of studies on the role of these proteins on the pathogenesis of AD, PD and other neurodegenerative diseases. However, it has only been more recently that protein aggregation has been studied in great detail on a molecular level.
Whilst the protein deposits found in AD and PD are thought of as archetypical amyloids, protein aggregation has been described as a general property of the polypeptide chain [13, 14] . Typically, the aggregation process starts as a consequence of protein misfolding; a protein loses its native conformation and acquires one that is able to self-interact. The process is facilitated in the case of intrinsically disordered proteins, such as Ab and aS, as their folding energy landscape makes them inherently prone to explore different conformations. Once a nucleus is formed, the aggregates can grow through monomer addition, and further secondary processes can occur to form additional nuclei. For example, secondary nucleation and fibril fragmentation processes have been included in a mathematical model describing protein aggregation to more accurately fit the available data [15] [16] [17] . Fragmentation describes the ability of fibrils to break apart and form additional fibrils which can themselves grow and fragment further. Secondary nucleation introduces the possibility that fibrils can recruit monomers to their surface and act as additional nuclei for the growth of other fibrils. Both of these processes may lead to an exponential increase in fibril mass, which may account for disease spreading and progression in the brain. For definitions of the various aggregate species, refer to Box 1.
Although much of our knowledge of protein aggregation has come from in vitro studies, fibrils found in vivo tend to be morphologically indistinguishable from those formed in the test tube [18, 19] . These in vitro studies have made use of recombinant proteins that are incubated under conditions favouring their aggregation, which can vary greatly depending on the protein [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . The resultant aggregation kinetics can then be measured and are usually separated into three main phases: the lag phase, the elongation phase and the final plateau [31] . These phases are identified as such based on observations made from quantifying protein aggregation using bulk techniques, rather than discrete microscopic steps, and are believed to be shared by all amyloidforming proteins. The nucleation phase is the name ascribed to the period of time between the initiation of aggregation and the formation of detectable protein aggregates. This phase is the start of amyloid formation, and as mentioned above, necessarily begins with the formation of seeding-competent aggregation nuclei. The elongation phase refers to the period of time where the length of aggregates increases. On the microscopic level, along with continued nucleation, the aggregates grow and associate to form mature amyloid fibrils. The final plateau phase is characterised by the detectable aggregates reaching a dynamic equilibrium with each other and monomeric proteins.
Despite the complications arising from their insolubility and high molecular weights, amyloid fibrils were the first aggregate species described [32] . However, much evidence points towards the earliest species as being the most toxic [33] [34] [35] [36] [37] [38] [39] [40] [41] . Unfortunately, these species are highly heterogeneous, rare and transient in nature, and so are difficult to study using traditional biochemical techniques. For this reason, many modern techniques have been developed and adapted to study the aggregates formed in this step of the fibril-formation process. This review describes some of these methods, and goes on to explain how they have led to key findings in the aggregation of the proteins associated with PD and AD, the most common neurodegenerative diseases.
common techniques makes use of the benzothiazole salt, thioflavin-T (ThT) [42] . Upon binding to b-sheetrich structures, such as amyloid fibrils, the fluorescence quantum yield of ThT increases by several orders of magnitude [43] , thereby allowing the quantification of fibril formation (Fig. 1A) . The dye can be added to time-points taken from an aggregation reaction, and its fluorescence measured in a conventional fluorimeter (ex situ). Alternatively, it can be added to a solution of aggregating protein in situ and the fluorescence increase can be measured continuously with a plate reader. However, care must be taken to ensure that the dye itself does not affect the aggregation process. The advantage of this method is that it is simple to implement, requiring inexpensive equipment and little training. Much work has also focused on fitting mathematical models to the resultant fluorescence traces to gain insights into the kinetics involved in the fibril-formation process, such as determining the relative contributions of primary nucleation, elongation, secondary nucleation and fragmentation [44] [45] [46] . However, such optical techniques only observe the ensemble fluorescence from the system, and so limited information on the individual species contributing to this enhanced fluorescence is obtained. Moreover, not all aggregates bind ThT, which means some species important to disease pathology may be missed [21] . For this reason, a range of new dyes have been developed, some of which can detect a wider range of aggregates [47, 48] .
Dynamic light scattering (DLS)
Whereas bulk optical methods enable the total relative b-sheet mass of a sample to be measured over time, other methods offer insights into the actual sizes of the species present. DLS is the scattering of laser light by small insoluble particles to gain information on the size distribution of a sample. This method is often used in the study of protein aggregates [49] , and allows information to be obtained on the size of the aggregates (Fig. 1B) . Once again, it has the advantage of being simple to implement and no potentially interfering dye or chemical is required. However, DLS provides the average size of the species present rather than the sizes of the individual aggregates. The technique is also biased towards larger species, which have a greater propensity to scatter light. Additionally, DLS has a practical resolution limit of approximately 1 nm which is imposed by factors such as sample purity and the wavelength of the laser being used.
Circular dichroism (CD)
In addition to the size distribution of aggregating species, the average protein structure can also be measured using techniques such as CD. CD exploits the ability of regular amino acid structures within proteins to rotate the polarisation of light to provide information on the secondary and tertiary structures of proteins. This is useful for studying protein aggregation, since many of the proteins that aggregate are intrinsically disordered in their native state, and so have very little distinct secondary or tertiary structure; however, when forming amyloid structures, the b-sheet content increases, and measuring this can provide structural insights into the fibril-formation process (Fig. 1C) [50].
Surface-based techniques

Quartz crystal microbalance
To overcome some of the shortfalls of ensemble techniques, surface-based methods have also been used to characterise the aggregation process. Quartz crystal microbalance (QCM) sensors are able to determine mass variation per unit area by measuring the change in frequency of a resonating quartz crystal. This method is sensitive enough to report on the change in mass of surface-attached fibrils and has enabled very precise measurements of the influence of solution conditions on aS fibril elongation to be obtained [51] .
Atomic force microscopy
Atomic force microscopy (AFM) enables the surface topography of a sample to be deduced as a cantilever and tip raster scans a surface [52] . A laser beam reflected from the tip is detected by a photodiode detector, enabling the topography of the sample to be mapped with a vertical resolution of greater than 1 nm although the horizontal resolution is lower. These techniques have the advantage of being label-free, and in the case of AFM, allow individual aggregates to be observed. However, they are sensitive to surface effects which may perturb the findings [53]; for example, fibrils may grow at different rates on the surface, and some species may have a greater propensity to adsorb on the surface than others.
Fluorescence-based single-molecule techniques
The protein aggregation process leads to the generation of a wide range of species, from highly heterogeneous oligomers, through to amyloid fibrils, which have a well-defined structure. For this reason, the ability to characterise individual aggregates using singlemolecule fluorescence methodologies has revealed much about protein aggregation. To visualise individual molecules, the signal-to-noise ratio must be high, and one way in which this is achieved is through the reduction in the excitation volume. There are two principal methods by which this is brought about: confocal microscopy and total internal reflection fluorescence (TIRF) microscopy.
Confocal microscopy techniques
In single-molecule confocal microscopy, a collimated laser beam is focused by a high numerical aperture objective lens to a diffraction limited spot (< 1 lm). As individual dye-tagged molecules are excited in the confocal volume, their fluorescence emission is collected by the same objective lens, filtered and passed through a pinhole (to reject out of focus light) and focused onto a highly sensitive avalanche photodiode detector ( Fig. 2A) . Confocal microscopy was first used in this way to study the aggregation of the SH3 domain of phosphatidylinositiol-3 0 -kinase (PI3-SH3) [54] . In this study, equimolar mixtures of two different dye-labelled PI3-SH3 solutions were incubated under conditions favouring protein aggregation, and regular samples were collected to be analysed using two-colour coincidence detection (TCCD). With TCCD, two confocal volumes of different wavelengths are overlapped, in this case 488 nm (blue) and 633 nm (red). As dye-tagged molecules transverse the overlapped volumes, they generate bursts of fluorescence. Monomeric PI3-SH3 only gave rise to a signal in either the blue-excitation or red-excitation channel, whereas the oligomers generated a coincident signal in both channels if they contained both dyes (Fig. 3A) . This method therefore provided the means to separate oligomeric events from monomers and the total intensity provided information about the sizes of the oligomers. In a similar technique, scanning for intensely fluorescent targets (SIFT) [55, 56] , the two overlapped laser beams are scanned through the sample to detect species.
In some cases, the different colour dye molecules in the oligomers formed are close enough for F€ orster resonance energy transfer (FRET) to occur between them. This allows for the use of one-color excitation (to excite the donor fluorophores), and emission in the acceptor channel denotes the presence of an oligomer (Fig. 3B ). This has been used to study the aggregation of a variety of proteins as the FRET efficiency can be used to determine the relative mean distance between the fluorophores, giving some insights into the monomer density within an aggregate [35, 57, 58] . Surface effects are removed in solution-based confocal microscopy; however, data interpretation is more complex, since structures must be inferred from bursts of fluorescence. Additionally, the low concentrations (sub-nanomolar) required for single-molecule confocal measurements may mean that many species dissociate upon dilution, and so are not observed. However, microfluidic devices to rapidly dilute samples before complexes have had the chance to dissociate have been designed, and these could go some way to remedy this potential problem [59] .
In contrast to discrete burst analysis, a confocal microscope setup can also be used to perform fluorescence correlation spectroscopy (FCS) [60, 61] . FCS relies on measuring temporal fluorescence fluctuations as multiple fluorophores occupy the confocal volume (concentrations of 1-100 nM). The careful analysis of such fluctuations through autocorrelation and fitting to relevant diffusion equations enables the determination of concentrations and diffusion coefficients. However, the method does not strictly observe individual molecules, and deconvolution of multiple populations can be troublesome.
Total internal reflection fluorescence (TIRF) microscopy techniques
In contrast to confocal microscopy, TIRF microscopy is usually a surface-based method. Total internal reflection occurs when a plane of light travelling through a transparent medium of a given refractive index is incident upon a dielectric interface with another medium of a lower refractive index at an angle greater than the critical angle. Despite being called total internal reflection, an electromagnetic wave termed the 'evanescent wave' penetrates a small distance into the second low refractive index medium, and this decays exponentially away from the interface. In objective-based TIRF microscopy [62] , collimated laser light from a high numerical aperture objective lens is reflected from the bottom of a glass coverslip containing aqueous solution, and the evanescent wave is used to excite a wide field typically < 200 nm into the sample (Fig. 2B) . The fluorescence is then collected by the same objective, filtered and focused onto either an electron-multiplying charge-coupled device, or a scientific complementary metal-oxide-semiconductor camera. TIRF microscopy can be used to directly visualise individual-labelled aggregates immobilised on a glass slide, allowing their physical size and structure to be imaged, down to a resolution of around 250 nm (the diffraction limit of visible light). The number of monomers present in an oligomer can be estimated using this method. As individual dye molecules within the oligomers photobleach, there is a stepwise decrease in the total intensity of each individual spot, and these can be counted to determine how many dye molecules were present in the oligomer. This becomes problematic if there are too many dye molecules present, but this can be avoided using sub-stoichiometric labelling [63] .
In the above-described methods, the protein-of-interest must be labelled with an organic fluorophore; however, this can be challenging, and in some cases may affect the kinetics of protein aggregation, or structures of the fibrils [64] . An alternative method uses dyes such as ThT coupled with TIRF microscopy to detect the protein aggregates. This has the advantage of not needing to have the dyes directly conjugated to the protein, and means that the method can be used to observe oligomers within biofluids such as cerebrospinal fluid [65] . However, the binding mechanism of such dyes is not fully understood. They may not bind to all aggregates, and could also bind other structures unrelated to amyloid.
Super-resolution microscopy
The diffraction of light limits optical microscopy to a resolution of around 250 nm. However, super-resolution methods [66] [67] [68] have enabled optical imaging at much higher resolutions, allowing structures as small as 5 nm to be characterised [69] . There are two main strategies permitting super-resolution microscopy to be performed. One approach, implemented on a scanning confocal microscope, termed stimulated emission depletion (STED) microscopy, limits the illumination of the sample to regions smaller than the diffraction limit [68] . The other strategy works by stochastically separating single fluorophores in time to gain resolution in space (stochastic switching and readout), and this can be done by various methods. Stochastic optical reconstruction microscopy (STORM) [67] relies on dyes stochastically photoswitching between dark and fluorescent states, allowing subpopulations to be localised individually. Photoactivated localisation microscopy [66] uses photoswitchable fluorescent proteins (usually switched to a longer wavelength through irradiation with ultraviolet light) to separate fluorescence from single emitters in time. Other methods, such as point accumulation for imaging in nanoscale topography (PAINT) [70] and uniform PAINT [71] rely on fluorescent molecules temporarily binding to surfaces, where they are localised to build up a super-resolved image. In adapted versions of this, various methods of achieving transient binding have been described, including using short DNA sequences (DNA-PAINT) [72, 73] . Additionally, a technique termed spectrally resolved PAINT (sPAINT) [74] uses the transient binding of the dye nile red to characterise the surface hydrophobicity of protein aggregates. The emission wavelength of nile red varies depending on the hydrophobicity of its environment, and so by detecting the wavelength in addition to the location of nile red binding events, hydrophobicity can be mapped at the nanoscale.
Higher resolution
Although super-resolution techniques can now readily achieve imaging with a resolution of greater than 20 nm, this is sometimes not sufficient to fully characterise the smallest of oligomers. Higher resolution methods are routinely used to determine the structure of protein aggregates. Transmission electron microscopy (TEM) uses a tightly focused beam of electrons to image the specimen as they pass through it, and gives rise to a resolution as high as 0.2 nm. Sample preparation for TEM is complex, and this limits its usefulness for looking at some structures. Notably, the Nobel prize in Chemistry has recently been awarded to the developers of cryo-electron microscopy (cryo-EM) [75, 76] . In this technique, the sample does not have to be chemically fixed, but is instead rapidly cooled to cryogenic temperatures, which means that the protein can be observed in its native state. However, the generation of a three-dimensional structure of proteins from cryo-EM relies on reconstructing images from many different projections, and this is challenging for highly heterogeneous specimens, such as oligomers. Nevertheless, it has been used to characterise the structure of purified kinetically trapped oligomers of aS [77] , tau filaments extracted from a human AD brain sample [78] , poly-glutamine expanded huntingtin fibrils from cultured neurons [18] and Ab fibrils [79] . Box 2 summarizes the various techniques, what samples they can be used on, and their useful concentration and resolution ranges.
Alzheimer's disease and the visualisation of amyloid-beta aggregates
The presence of extracellular plaques composed of the Ab peptide is a pathological hallmark of AD [7] . Ab is formed and released into the extracellular space through the cleavage of the amyloid precursor protein [80] . This cleavage can be performed by several proteases such as ADAM 10, BACE 1, a-and c-secretase, leading to the formation of various N-and C-terminal isoforms of Ab exist [81, 82] . When the expression and degradation of Ab is controlled, there is evidence suggesting that the peptide has several important and possibly neuroprotective functions, such as regulating synapse activity [83] . However, when the homeostatic balance of Ab production is disturbed, the aggregation of the peptide plays a key role in neurodegeneration [84] [85] [86] . As a result, much effort has been dedicated to characterise aggregated Ab species. It is not clear precisely which factors lead to the loss of the normal balance; however, the ratio of the most abundant cleavage products Ab1-40 and Ab1-42 has been implicated to be important to AD pathogenesis, adding greater complexity to the oligomer formation process [87] .
Due to the high aggregation propensity of Ab, it can be challenging to obtain a homogeneous monomeric sample, as the molarities required for many ensemble methods are high enough to trigger aggregation. This makes studying the kinetics of aggregation troublesome, since there may already be seeds present which can complicate the reaction. Despite this, a variety of soluble aggregates have been studied, but most have not been characterised beyond the use of SDS/ PAGE and antibody reactivity [88] . Beyond this, various structural and functional details have been obtained for water-soluble, non-fibrillar Ab assemblies [88] . Structures that have been described include protofibrils [89, 90] , Ab-derived diffusible ligands [91, 92] , globulomers [93] , spheroids [94, 95] , disulphide cross-linked Ab [27], cell-derived SDS-stable low n-oligomers [96, 97] , Ab*56 [98] and a brain-derived SDS-stable Ab-dimer [27, 88] . They all have in common distinctly different biological effects compared with mature fibrils although some of them contain cross b-sheet structures, such as the protofibrils [89, 90] .
The most commonly used techniques to characterise Ab aggregates are AFM and TEM. Both techniques are used to examine the morphological differences exhibited by various aggregates, such as elongated amyloid fibrils and small, globular oligomers [99] [100] [101] [102] . These approaches have been used to study all species throughout the aggregation process, as well as comparing the structure of aggregates produced by mutant variants [103, 104] . AFM studies showed that not only the morphology of aggregates changed throughout the aggregation process, but Young's modulus (a measure of stiffness) also increased, suggesting an internal structural rearrangement [105] . Furthermore, Ab fibrils have been resolved at the atomic level with X-ray crystallography and solid state-NMR including variations in clinical subtypes of AD [106] [107] [108] . Structures of the cross b-sheet amyloid state are reviewed in great detail by Eisenberg and Jucker [109] . A complete de novo 42 amino acid atomic model of Ab fibrils has also recently been solved via cryo-EM [110] .
Fluorescently labelled Ab peptide variants are readily available as solid-phase synthesis allows the efficient site-specific conjugation of single fluorescent tags to the Ab peptides. This has facilitated the use of highly sensitive single-molecule methods to study the properties of individual Ab aggregates, especially oligomers. The application of single-molecule methods to study early aggregates has provided insights into the size distributions and effects of very early aggregates [111] [112] [113] . Narayan and colleagues found that Ab oligomers initiated neuronal damage on astrocytes [114] and were sequestered by an extracellular chaperone [112] . They described the oligomers as mostly below 10-mers in monomer units, and using TCCD it was possible to study these at levels much closer to their physiological concentrations compared to other techniques [112] . Furthermore, these fluorescent methods have been used to show how oligomers preferentially interact with cell membranes relative to monomers [115] . Subsequently, Flagmeier et al. [86] used an ultrasensitive membrane disruption assay to show that Ab42 oligomers but not monomers or fibrils are able to disrupt lipid vesicles at picomolar concentrations.
Aggregate analysis via TCCD and confocal photobleaching trajectory analysis [111] are limited by acquisition times and instrumental dead times. Whilst the timescale of in vitro aggregation of the majority of amyloidogenic proteins is sufficiently slow to take full advantage of these techniques, the temporal resolution can be a limiting factor for the ability to detect early aggregation events of proteins with fast aggregation kinetics, such as Ab42. To overcome this limitation, microfluidic strategies have been used, whereby the aggregation mixture is rapidly flowed through the confocal volume to increase the rate of detection, and therefore increase the time-resolution of the methods [57] .
Two-colour coincidence detection measurements of co-oligomer formation between Ab40 and Ab42 helped generate a thermodynamic model of the peptides' aggregation propensities [116] . It should be noted that the ability to size aggregates from TCCD and smFRET measurements is limited due to several factors such as the inhomogeneity of the confocal volume and fluorescence quenching at high label densities. Improvements to the former have been suggested by Murphy et al. through the use of Bayesian Inference [117] , which led to the data analysis on population sizes and intramolecular distance being more robust than simple threshold-based analysis, especially in more complex datasets.
Super-resolution techniques have been used to probe the seeding capacity of Ab aggregates in addition to the morphology of aggregates in CSF [118, 119] . By seeding fluorescently labelled Ab40 with brain-and CSF-derived Ab from AD and control patients it has been shown, using dSTORM, that seeding capacities and elongation rates were dependent on aggregate size [120] .
To perform label-free imaging in vivo, there has been a surge in the development of fluorescence imaging probes with similar properties as ThT and thioflavin S. Notably, the class of oligothiophenes has been used to image Ab aggregates in their pre-fibrillar and fibrillar state both in vitro and in vivo (Fig. 4) [121] [122] [123] . Interestingly, these dyes show different spectral footprints for the different amyloid topologies of Ab and tau [124] . Similarly, the hydrophobicity reporter dye nile red has been used to spectrally super-resolve local hydrophobicity propensities of amyloid aggregates using sPAINT [74] .
A different approach in understanding the molecular mechanisms of aggregation, and hence oligomer formation, is through the combination of high-quality kinetic data and kinetic modelling. This work on Ab has been pioneered by the Knowles and Linse groups. High purity recombinant monomeric Ab42 has led to robust aggregation kinetics which has enabled the use of global fitting models to get insight into molecular mechanisms of the underlying processes [125] [126] [127] .
An online modelling platform has been made available to investigate the effect of interactions of Ab with, for example chaperones [128] or antibodies [129] and to model molecular mechanisms for other amyloid proteins [126] . This has shown that Ab42 aggregation is strongly dominated by secondary nucleation, and hence the presence of seeds has an autocatalytic effect on the aggregation process [15] . However, care needs to be taken when inferring in vivo mechanisms from in vitro models, as some of the effects may be compounded by cellular components, for example fibril seeding on the membrane.
The application of the above-mentioned advanced biophysical methods has led to insights into the molecular mechanisms underlying Ab aggregation, and has given us insights into some structural features of the resulting soluble aggregates and amyloid fibrils. One of the main challenges is to link these molecular mechanisms and structural features to the resulting neurological effects and finally to the clinical manifestation of the disease. The prolonged time-course of the disease and the low Ab concentration in the extracellular space are of particular interest. In vitro, Ab aggregation time-courses are usually studied over hours at concentrations that are orders of magnitudes higher of what is found in the CSF [130] . Furthermore, the interactions and interplay between different Ab peptide isoforms and with other amyloid-forming proteins have not been conclusively explored. The application of the techniques to describe here could allow the investigation of these problems at the atomic and molecular level and help understand the neurobiology of these diseases.
Tau oligomers and filaments
The aggregation of the microtubule-associated protein tau into intracellular deposits plays a central role in the pathogenesis of AD and more than 20 other neurodegenerative disorders, collectively termed tauopathies [131] . Six different tau isoforms are produced in the adult human brain by alternative splicing of the microtubule-associated protein tau mRNA [11, [132] [133] [134] [135] [136] . These have up to two N-terminal inserts and either three or four repeat regions (termed R1-R4) in the C-terminal half [137] . The vast majority of tauopathies are sporadic diseases with age being the main risk factor; however, almost 80 pathogenic exonic missense and intronic silent mutations in the tau gene have been found in inherited cases of frontotemporal dementia [138] [139] [140] [141] [142] . These mutations tend to cluster around the repeat regions of tau which mediate microtubule binding and play an important role in the aggregation of tau as they form a large part of the core region of tau filaments [78, 143] . Intronic mutations and some mutations in exon 10 interfere with the alternative splicing of tau mRNA, increasing the amount of four repeat tau over three repeat tau. Pathological tau is hyperphosphorylated and contains about 8 mol of phosphate per mole of protein compared to 2-3 mol/mol of protein in physiological tau [144, 145] . Atomic force microscopy and TEM have offered some important insights into the aggregation mechanism of tau. Notably, due to their high resolution, these techniques were successfully used to study small oligomeric tau species as well as ultrastructural properties of filamentous tau. Barrantes et al. used AFM and spectroscopy to study tau aggregation in vitro in the absence of any inducers of aggregation. They found that tau rapidly forms heterogeneous granular oligomers with a height of 6-16 nm at room temperature, whereas fibrillar material was detectable only after a few months of incubation. Furthermore, they showed using force spectroscopy that the interaction between tau monomers is relatively strong and required unbinding forces in the order of ligand-receptor or antigen-antibody interactions [146] . The formation of prefibrillar granular tau aggregates of similar size (15-25 nm) was also found in two further studies, where tau aggregation was induced by the addition of heparin [147, 148] . These granular aggregates formed at the end of the lag phase and appeared to be ThTactive, indicating that these species are b-sheet-rich aggregates. Interestingly, Maeda et al. could isolate such granular tau aggregates from AD patients as early as Braak stage I, before filamentous tau was detectable. The authors therefore suggested that these species represent early tau assemblies preceding mature filaments [147, 149] .
High-resolution AFM and TEM were also used to assess the morphology and mechanical stability of tau fibrils formed in the presence of heparin. The high resolution of these techniques allowed the determination of the thickness and periodicity of tau fibrils and demonstrated their polymorphic nature [150] . In the same study, it was also shown that hydrophobic surfaces or mechanical force by the AFM cantilever can lead to the fragmentation of tau fibrils into species with a similar morphology to the granular oligomers described above. This suggests that granular tau species could not only exist as a precursor of filaments, but could also be produced by the fragmentation of fibrillar species. This highlights that care must be taken to identify and avoid artefacts when surfacedependent methods are employed to characterise amyloid species. In a second study by Wegmann et al., high-resolution AFM was used in force-volume (FV) mode to study the orientation of the N-and C-terminal projection domains of full-length tau [151] . FV-AFM is ideal to image biomolecules with high force sensitivity, and to simultaneously map their physicochemical properties at molecular resolution (1-2 nm) [152] . Using FV-AFM, the authors described the projection domains of tau, the 'fuzzy coat', as highly flexible polyelectrolyte brush surrounding the fibrillar core of tau. This coat is around 16 nm thick and mechanically up to four times softer than the fibrillar core [151]. Scanning TEM is able to provide mass per unit length measurements and has shown that tau filaments have a mass per length of 160 kDa ( 3.5 monomers) per nm for recombinant full-length tau (2N4R D280K tau) and 130 kDa per nm for AD paired helical filaments (PHFs) [153] .
Notably, the advent of cryo-EM has recently allowed the first atomically resolved (3.4-3.5
A) visualisation and reconstruction of PHFs and straight filaments (SFs) extracted from a patient with AD [78] . This work confirmed that tau filaments are formed of two identical protofilaments with C-shaped subunits and that PHFs and SFs differ in the orientation and packing of these two protofilaments, as previously suggested based on lower resolution electron micrographs [154] . In their work, Fitzpatrick et al. provide, for the first time, full atomic maps for the tau filament core in PHFs and SFs (see Fig. 5 ). This core region spans residues 306 to 378 of full-length tau, corresponding to the repeat regions R3 and R4 and a short stretch beyond R4 [78] .
Similar to Ab, important mechanistic insights into the aggregation of tau have been gained by kinetic modelling. Whilst tau aggregation has been described by simple nucleation-elongation models [155, 156] , the in vitro aggregation process of tau is complex as inducers of aggregation seem to act as ligands or allosteric regulators which bind transiently to tau [156] [157] [158] [159] [160] [161] . This catalyses a conformational change of tau, leading to the rapid formation of small nuclei. The lowered thermodynamic barrier of nucleation results in rapid aggregation kinetics even at very low protein concentrations, and without the presence of the classical lag time, a process which cannot necessarily be assigned to a canonical nucleation-polymerisation model [157] . Using confocal smFRET, Shammas et al. were able to track the evolution of transient K18 tau oligomers during aggregation, and demonstrated that the diseaseassociated tau mutations DK280 and P301L lead to the formation of around 50-fold more transient oligomers compared to wild-type tau during their aggregation (see Fig. 6B ) [162] . Similar trends were observed by Kumar et al., who used AFM and time correlated single photon counting (TCSPC) to study the oligomerisation of K18 tau [163] . Furthermore, kinetic analysis of the oligomerisation process revealed that K18 tau aggregation, similar to aS [35], proceeds via monomeric assembly into small oligomers followed by a slow structural conversion step before fibril formation (Fig. 6) [162] . Rate constants of the fundamental microscopic reaction steps could be determined, showing that the disease-associated mutants have an increased nucleation rate compared to wild-type tau. As the primary nucleation of wild-type tau is comparatively slow and acts as a bottle-neck for aggregation, the authors predict that small amounts of seeds have a large effect on the amplification of wild-type tau aggregates in cells. In contrast, seeding is thought to play a less significant role for mutant tau with aggregation being dominated by primary nucleation by wild-type tau as compared to mutant tau [164] . Whilst a recent study provided some indirect evidence for secondary processes to occur during the aggregation of the short repeat domain construct K18 tau [165], the aggregation kinetics of full-length tau appear not to be dominated by secondary processes such as secondary nucleation or fragmentation [156] . The high sensitivity of smFRET for small oligomeric species has also been exploited to study the interaction of the molecular chaperone Hsp70 with different aggregate species of the K18 ΔK280 tau variant. This study showed that Hsp70 slows down the nucleation process of tau, stabilises oligomeric species and inhibits their growth into fibrils [166] . Similar findings were made in a second study, comparing the action of Hsp70 and a second chaperone, HspB1, on K18 and full-length tau aggregation using FCS and NMR [167] .
Similar to TCCD and FRET, Giese and co-workers developed a method for the sensitive detection of protein aggregates. Using their technique, referred to as SIFT, the Giese lab identified the trivalent metal ions Al 3+ and Fe 3+ and organic solvents, such as dimethyl sulfoxide, as inducers of tau self-oligomerisation and co-aggregation with aS [168]. The latter was found to be moderately enhanced by tau phosphorylation [169] . Furthermore, they used FCS to study the effect of limited proteolysis of tau on its oligomerisation propensity. They showed that limited proteolysis by the extracellular matrix-metalloproteinase-9 (MMP-9) leaves the repeat domain of tau largely intact, leading to the formation of an aggregation-prone fragment of tau [170] .
In a number of studies, Rhoades and colleagues investigated interactions of tau with pathological and physiological targets. Using FCS, they show that lipid bilayers catalyse the aggregation of K18 tau by serving as a nucleation surface. Once a critical surface density is reached, tau aggregates into ThT-active species incorporating the lipid vesicles [171] . In a second study, Rhoades and co-workers systematically introduced FRET pairs distributed over the whole tau sequence to study its conformation in the absence and presence of an aggregation inducer, heparin [161] . In agreement with a previous bulk study by the Mandelkow lab [172] , the N-and C-termini of monomeric tau were found to fold loosely over the microtubule repeat. Upon addition of heparin, tau undergoes a critical conformational change characterised by the loss of these long-range contacts and a contraction of the repeat region [161] . Furthermore, the distance between the different FRET pairs derived in the smFRET experiments described above served as constraints to model the conformational ensemble of tau during aggregation [173] . It should be noted that whilst FRET provides valuable conformational information under physiological conditions, conformational artefacts may arise from the covalent attachment of the FRET dyes to the protein of interest.
Another approach making use of organic fluorophores covalently attached to tau was chosen by Kaminski and Kaminski-Schierle. They demonstrated that the fluorescence lifetime of labelled aggregates changes with the appearance of b-sheet containing structures and that this change can be used to assess the aggregation state of amyloidogenic proteins in vitro and in vivo [174] . In a recent study by Michel et al., this principle was used to track the fate of monomeric K18 tau added to the extracellular medium of SH-SY5Y cells [175] . Importantly, in this study, 10% labelled K18 tau-AF488 and 90% unlabelled protein were used to reduce dye-dependent artefacts. Confocal TCSPC microscopy showed that tau was rapidly taken up into endosomal compartments and formed aggregates which appeared to seed endogenous tau [175] . Furthermore, two-colour dSTORM imaging of the cell medium revealed that cells seeded with monomeric tau expelled fibrils into the cell medium consisting of both endogenous and exogenously added tau. Interestingly, single fibrils contained multiple regions containing exogenous tau ('seed tau') rather than one region comprising the 'core seed', which is not compatible with the simple elongation by monomer addition mechanism conventionally assumed for seeded aggregations. Fluorescence lifetime measurements were also used to assess the density of K18 tau fibril clusters as the fluorophores undergo strong self-quenching when in close proximity to each other [176] . Hereby, it was also sufficient to have a fraction of the protein labelled with the organic fluorophore, requiring labelling ratios of 10% or higher. Surprisingly, whilst this assay appeared to be very efficient at detecting the formation of fibril clusters, fluorophores in single fibrils were not quenched and thus this method is not suitable to study the early aggregation steps such as the conversion of disordered oligomers to well-ordered fibrils [176] .
Whilst the use of partially labelled tau samples, in which only a fraction of tau molecules is fluorescently labelled, leads to a decreased detection efficiency for smaller protein aggregates such as very small oligomeric species, it can be an efficient strategy to reduce the influence of the label on the aggregation behaviour. Generally, this approach can therefore be a good compromise when the amyloidogenic protein of interest is difficult to label in a non-perturbative way and ultrasensitive measurements are not crucial for the study to be conducted.
Notably, for in vivo studies, direct labelling is not applicable and immunostaining with labelled antibodies is commonly performed. Benda et al. demonstrated the use of STED microscopy to image immunostained tau aggregates in 50 lm AD brain sections. They achieved a spatial resolution of 77 nm, allowing the visualisation of single fibrils within NFTs. Also, small tau puncta and fibrillar fragments were observed in close proximity to the tangles. Furthermore, the resolution in the x-y plane could be maintained when zstacks were recorded over 20 lm, allowing threedimensional surface rendering of NFTs (although with confocal axial resolution). Ultrastructural features of filaments could not be resolved [177] .
In summary, some important insights have been gained into the aggregation pathway of tau by advanced biophysical methods such as TEM and fluorescence microscopy. For tau, remaining challenges are a more comprehensive characterisation of small soluble species of the full-length protein in vitro and in vivo, and the identification of mechanisms of toxicity conferred by such species. This field will benefit from improved labelling strategies, for example, through more readily available site-specific labelling strategies or the development of nanobodies for tau, and new super-resolution techniques such as DNA-PAINT [73] . Furthermore, the ability to resolve aggregates at the atomic level by cryo-EM [75, 76] will allow more profound insights into the ultrastructural features of tau filaments and will provide important insights into the prion like character of tau, for example, through the analysis of filaments found in other tauopathies.
Alpha-synuclein and Parkinson's disease
a-Synuclein is the major component of Lewy bodies found in PD and in other synucleinopathies [12] . It was one of the first described intrinsically disordered proteins and has also been associated with amyloid plaques in AD [178] . In addition to its presence in Lewy bodies, the link between aS and PD is also evidenced by the duplication and triplication of the SNCA gene encoding aS leading to autosomal dominant forms of the disease [179, 180] , in addition to single residue missense mutations also causing early-onset forms of PD [181] [182] [183] [184] [185] [186] .
The primary structure of aS can be divided into three regions: the positively charged N-terminal region (residues 1-60), which contains imperfect repeats that resemble the apolipoprotein helical sequence and drive the acquisition of alpha-helix upon binding to membranes [187, 188] ; the central hydrophobic domain (residues 61-95), also called non-amyloid b-component (NAC), which is responsible for its aggregation and leads to the formation of beta-sheet during fibril formation [189, 190] and finally, the acidic C-terminal end (residues 96-140), which has a high proportion of negatively charged residues and prolines, contributes to protein solubility and has never been associated with a-helical or b-sheet secondary structure [191] . aS has been described as a chameleon, as it is able to acquire different secondary structures depending on interaction with lipids and other proteins [192] .
Despite the large majority of PD cases being sporadic [193] , it is interesting to note that all diseasecausing mutations are in the same N-terminal region of the protein just prior to the NAC region, indicating that mutations can influence the conformational landscape of aS and modulate its propensity to acquire secondary structure [194] . It has been shown that these mutations can indeed modulate in vitro and in vivo aggregation properties of aS [29, [195] [196] [197] [198] [199] . Some mutations are known to increase the aggregation tendency of aS, such as A53T and E46K [195, 198, 200] , while others delay fibril formation, for example, A30P and G51D [29, 199] . For the A30P mutation in particular, the hypothesis that aS forms a trapped population of oligomers that cannot go on to form fibrils has led to the belief that oligomers are responsible for inducing toxicity in PD [29] . However, as for other aggregating proteins, direct detection of these highly heterogeneous species has remained challenging. Alongside methods developed for studying other aggregating proteins, a number of techniques for characterising aS aggregates have also been established.
One of the earliest approaches was to find conditions that generate a large amount of oligomers. One such method involved incubating concentrated solutions of aS on ice, leading to the formation of annular oligomers analysed using TEM [201] (see Fig. 7 ). Other protocols involve incubating aS at 37°C [77, 202] and inserting a size exclusion [203, 204] or diafiltration step [205] to generate adequate amounts of oligomers for further studies. One such study [77] purified a kinetically trapped oligomeric species that was accurately characterised using fluorescence, CD, AFM, DLS and cryo-EM. However, many types of such oligomers often do not proceed to form fibrils, but are instead trapped in an energy well for alternative aggregation/folding of aS, and so may not represent the real heterogeneity of aS oligomers [203, [206] [207] [208] . However, this is not always the case, and in other cases, purified oligomers are able to go on to form fibrils [209, 210] . Additionally, the type of [201] formed by dissolving lyophilised aS in PBS at a concentration ranging from 300-700 lM and incubating on ice for 30-60 min. Oligomers were then filtered through 0.22 lm filters and separated from monomers by gel filtration. Scale bar is 50 nm. (B) Spherical oligomers as observed by Ehrnhoefer et al. [208] . One hundred micromolar aS was incubated in the presence of Nepigallocatechin gallate (1 : 10) and incubated in TBS buffer on a rotary shaker (conditions favouring aggregation) at 37°C. Oligomers were separated from monomers and other aggregates by gel filtration. Scale bar is 100 nm. Figure reproduced from Ref. [201, 208] .
oligomers formed is strongly dependent on the experimental conditions used [211] . Several additives have been used to boost the formation of these aggregates. Dopamine and fatty acids are often used to stabilise oligomers [206, 210, [212] [213] [214] [215] [216] . Oligomers obtained with these techniques have b-sheet content, in some cases ahelical content, are stable upon shifts in pH and temperature [217] and can interact with lipid membranes and cells [202, 209, [217] [218] [219] [220] . These and other conditions have been extensively reviewed recently [221] .
To the best of our knowledge, aS oligomers obtained from brain extracts have not been structurally characterised, which means that there is no possibility to compare these oligomers with the ones formed in vitro. The end point of aggregation in vivo is amyloid fibrils, which are similar to those formed in vitro [18, 19] , thus suggesting that similar intermediate species may be formed throughout the processes. In an attempt to characterise some of the most elusive species, cross-linking techniques have been applied to capture the transient oligomers in vitro [222, 223] . The resultant aggregates have been characterised in terms of their sizes, through use of DLS and SDS/PAGE gels; however, these cross-linked oligomers do not readily form fibrils, as their polypeptide chains cannot adapt or recruit further monomers for elongation [222] . Thus, it is not clear how well these findings represent native oligomers formed within the brain.
Native mass spectrometry has also been used to investigate the sizes of aS oligomers [224] . However, this approach requires the oligomers to be dissolved in specific buffers, which may perturb their structures [225] [226] [227] . Data obtained from mass spectrometry describe the presence of different conformational states of monomer, and can detect the formation of dimers [225] . Moreover, drift-time analysis has been used to gain insights into oligomer topology. Oligomers ranging in size from dimers to hexamers have been described [226] ; however, larger oligomers cannot be analysed using such a method. As for Ab and tau, fluorescence methods have successfully been employed for the sensitive and specific detection of intermolecular interactions. Structurebased non-covalent fluorescent probes have been developed to specifically detect the presence of oligomers, or pre-fibrillar species during aggregation [228, 229] . Alternatively, fluorophores have been conjugated to specific sites of aS using maleimide chemistry on cysteine residues inserted by site-specific mutagenesis on the aS polypeptide chain [173, 230, 231] . These studies use properties such as pyrene excimer formation to be able to detect intermolecular contacts between aS monomer units. The presence of fluorescent probes on aS also allows FCS measurements to be performed, which enable estimation of size distributions of oligomers from their diffusion coefficients [173] . As is the case for tau, the labelling site for the fluorophores needs to be selected with care: it is important to ensure that the label does not introduce artefacts or affect oligomer formation.
One of the first single-molecule fluorescence techniques applied to study the aggregation of aS was SIFT [56, [232] [233] [234] . As mentioned above, this method looks at the intensities of individual molecules and assigns the brighter bursts of fluorescence as originating from oligomeric species. Furthermore, photobleach step analysis allowed the determination of oligomer sizes in sub-stoichiometrically labelled aS. For this analysis, a TIRF setup was used to detect single aggregates rather than a confocal setup as described for Ab above [63] . The accurate counting of photobleaching steps is usually limited to there being less than 10 fluorophores present; in any case, a purified oligomer containing 31 monomer units was identified. However, this method is biased for the detection of brighter species. Additionally, the analysis assumed only one size of oligomer, which may not have been the case.
Through the introduction of a cysteine in the aS sequence at position 90, which is at the edge of the fibril-forming region, detailed analyses on the oligomer formation process have been achieved using the singemolecule fluorescence methods TCCD and smFRET [35, 57, 58] . These experiments revealed the existence of two oligomeric populations, with different 'compactness', resistance to proteinase-K degradation and stability in low ionic strength buffers [57] . Furthermore, these techniques enabled a structural comparison of pathologically related mutants in solution, revealing Box 2 Overview of possible techniques for the measurement of various aggregated proteins and their typical application spectrum. A green tick means that the indicated technique is typically viable within the given parameters of the sample, whereas the red crossed circle indicates it is not. This table is by no means exhaustive and under certain circumstances measurements are still viable outside the indicated ranges and applications. It should give, however, a quick visual aid to find the right biophysical technique for specific applications observing amyloid proteins.
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subtle structural differences between the oligomers generated by mutants in comparison with the wild-type protein [58, 235] . The application of this method to aggregation kinetics run at different concentrations of aS permitted the inference of a kinetic model for aS oligomer formation in vitro, enabling the calculation of conversion rates between the two different types of oligomers [236] . Unlabelled aggregates of aS have been directly observed using ThT and TIRF microscopy. This technique, referred to as Single Aggregate Visualisation by Enhancement (SAVE) imaging [65] , has negated the need for a conjugated organic fluorophore, and so has enabled oligomers to be studied within biofluids. This has led to the finding that cerebrospinal fluid from PD patients contains a greater oligomer load than those samples from healthy controls (Fig. 8) . Additionally, sPAINT [74] has been used to look at both oligomers and fibrils of aS, and it was shown that the oligomers have a higher surface hydrophobicity than the fibrils, which may explain their greater toxicity.
Despite the ability to observe oligomers in human biofluids, techniques still need to be developed and adjusted to observe native oligomers in cells or in vivo. Due to the low concentration and low stability of these species, oligomer visualisation within cells is challenging, and purification may affect their structure. So far, the large majority of detection methods for proteins in vivo is based on the use of antibodies [237, 238] . A good number of techniques have been applied to detect aS self-interaction using complementation assays or proximity ligations assays [239] [240] [241] [242] [243] or confocal microscopy methods [244, 245] .
Conclusion
The rapid development of biophysical methods in the previous decades has clearly led to a greater understanding of some of the molecular processes in neurodegeneration. In particular, these studies were prevalent for proteins available in high amounts through synthetic or recombinant protein production. Both details on the atomic structures of amyloid fibrils, as well as their behaviour within cellular models have been revealed by these methods. Additionally, the kinetics of protein aggregation is now well understood, both in terms of the microscopic processes involved, and which of these dominate for the various proteins. These details enable the rapid assessment of inhibitory factors, and such methods may serve future roles as diagnostic tools, which are vitally needed if a therapeutic strategy is to be developed for neurodegenerative diseases.
Despite the clear advantages of many advanced biophysical methods, their application requires specialist training and equipment and this significant investment of resources places a practical limit on the widespread use of these techniques. The development of new techniques and the on-going improvement of existing techniques towards faster acquisition times and higher quality data output will allow the application of the techniques to a broader range of problems. At the same time, biophysical studies need to become more comprehensive, for example by looking for common properties across different amyloidogenic proteins, but also through the use of more biologically relevant samples such as animal model or human post-mortem tissues. Both of these considerations call for a tighter collaboration between different labs to make pivotal advances in understanding neurodegenerative diseases. Taken together, the continuous improvement of existing biophysical tools such as super-resolution microscopy and the development of new techniques such as cryo-EM, as well as the improved access to a wide range of different samples, will yield new insights into the pathogenesis of neurodegenerative diseases and will pave the way for future therapies. Recognizing and avoiding artifacts in atomic force microscopy imaging. In Atomic Force Microscopy in
